Foamix claims goal-winning success in twin pivotal studies for rosacea — shares spike
The roller coaster ride that Foamix Pharmaceuticals has taken investors on is on an upswing track this morning. The biotech reported that its topical formulation …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
